ESTADÍSTICA MULTIVARIANTE APLICADA
Escuela de doctorado
Hospital Vall d'Hebron
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (9)
2024
-
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
eClinicalMedicine, Vol. 71
-
Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data
Journal of the European Academy of Dermatology and Venereology
2023
-
ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482
2019
-
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation
Annals of Hematology, Vol. 98, Núm. 9, pp. 2151-2162
2014
-
Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: An Allergists' Consensus
Clinical and Translational Allergy, Vol. 4, Núm. 1
2013
-
Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy
Immunotherapy, Vol. 5, Núm. 12, pp. 1295-1303
2012
-
The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome
Leukemia Research, Vol. 36, Núm. 3, pp. 287-292
2011
-
Prognostic impact of severe thrombocytopenia in low-risk myelodysplastic syndrome
Cancer, Vol. 117, Núm. 24, pp. 5529-5537
2007
-
Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: The ESPRINT questionnaire
Value in Health, Vol. 10, Núm. 6, pp. 466-477